St. Anna Children's Cancer Research Institute (CCRI)
Johannes Pfeifenschneider is a Scientific Project Manager at St. Anna Kinderkrebsforschung since April 2023, bringing extensive experience in research and business development. Prior to this role, Johannes served as a Business Development Officer at the Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases from August 2018 to March 2023. Johannes also held positions as a Postdoctoral Researcher at Kansai University and the University of Bielefeld, working on enzyme technology, metabolic engineering, and various aspects of protein production and purification. Johannes completed a PhD in Molecular Biology/Biotechnology at Bielefeld University, where previous degrees include a Master of Science in Genome-based Systems Biology and a Bachelor of Science in General Biology.
This person is not in any offices
St. Anna Children's Cancer Research Institute (CCRI)
The St. Anna Children's Cancer Research Institute (St Anna CCRI), located in the center of Vienna, the world's most livable city and one of Europe's most important places for biomedical research and life sciences, is an internationally renowned multidisciplinary research institution with the aim to develop and optimize diagnostic, prognostic, and therapeutic strategies for the treatment of children and adolescents with cancer. To achieve this goal we combine basic research with translational and clinical research and focus on the specific characteristics of childhood tumor diseases in order to provide young patients with the best possible and most innovative therapies. Dedicated research groups in the fields of tumor genomics and epigenomics, immunology, molecular biology, cell biology, bioinformatics and clinical research are working together to harmonize scientific findings with the clinical needs of physicians to ultimately improve the wellbeing of our patients. Through close cooperation between clinic and research, the CCRI provides an ideal environment for cutting-edge research and its translation into clinical practice. To achieve our ultimate goal of advancing the well-being of patients, the CCRI constantly pushes scientific boundaries and strongly promotes close collaboration and exchange with external institutions like the Medical University of Vienna, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA) and the Institute of Molecular Pathology (IMP).